Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

U.S. stocks are pulling back from their all-time highs as some of the steam comes out of Wall Street’s long, record-breaking ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...

Key Takeaways Activist investor Starboard Value reportedly has taken a large stake in consumer health care products maker ...

Confounding data from a Pfizer clinical trial have rattled the field of gene therapy for Duchenne muscular dystrophy ...

Starboard Value has amassed a significant stake in Kenvue, which spun out of Johnson & Johnson in mid-2023, according to ...

Kenvue shares jumped premarket after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the ...

AI search startup Perplexity aims for $8B valuation in new round. UBS sells 50% interest in Swisscard to Amex - report.

Activist investor Starboard Value has built a stake in consumer-products company Kenvue Inc., seeking changes that would ...

Shares of Kenvue rose more than 5% in premarket trading Monday after The Wall Street Journal reported that activist investor Starboard Value has built a sizable stake in the consumer-products maker ...